Braingrade

Braingrade is a private neurotechnology company founded in 2019, with headquarters in Wilmington, Delaware, and an additional location in Berlin, Germany. The company focuses on developing advanced brain implants, specifically deep brain stimulation (DBS) and brain-computer interface (BCI) devices. These innovations aim to preserve brain health and enhance human cognition, particularly for patients with Alzheimer’s disease. The core product of Braingrade is an intelligent brain implant system that combines DBS and BCI technologies. This system provides targeted neurostimulation to support cognitive function and slow the progression of neurodegenerative diseases. Braingrade collaborates with memory enhancement researchers, neurosurgeons, and neurologists to create solutions that help Alzheimer’s patients live longer, more independent lives by maintaining cognitive function. Braingrade's products are designed for patients suffering from Alzheimer’s and other cognitive impairments, as well as healthcare providers seeking innovative therapeutic options to improve patient outcomes. The company is dedicated to enhancing the quality of life for those affected by neurodegenerative conditions.

• Employees 4
• Founded 2019